2023
Coverage by examinations associated with early detection of colorectal neoplasia in the Czech Republic
NGO, Ondřej, Kateřina HEJCMANOVÁ, Štěpán SUCHÁNEK, Lucie PEHALOVÁ, Ladislav DUŠEK et. al.Základní údaje
Originální název
Coverage by examinations associated with early detection of colorectal neoplasia in the Czech Republic
Autoři
NGO, Ondřej (203 Česká republika, domácí), Kateřina HEJCMANOVÁ (203 Česká republika, domácí), Štěpán SUCHÁNEK (203 Česká republika), Lucie PEHALOVÁ (203 Česká republika, domácí), Ladislav DUŠEK (203 Česká republika, domácí), Miroslav ZAVORAL (203 Česká republika), Jan BURES (203 Česká republika), Bohumil SEIFERT (203 Česká republika), Karel HEJDUK (203 Česká republika, domácí), Norbert KRAL (203 Česká republika) a Ondřej MÁJEK (203 Česká republika, garant, domácí)
Vydání
European journal of public health, OXFORD, OXFORD UNIV PRESS, 2023, 1101-1262
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30304 Public and environmental health
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.400 v roce 2022
Kód RIV
RIV/00216224:14110/23:00134638
Organizační jednotka
Lékařská fakulta
UT WoS
000984197800001
Klíčová slova anglicky
colorectal neoplasia; early detection; Czech Republic
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 25. 9. 2023 10:02, Mgr. Tereza Miškechová
Anotace
V originále
Background Coverage by examinations is a crucial indicator of the future impact on the burden of colorectal cancer (CRC). The study aimed to evaluate coverage by examinations associated with CRC screening and early cancer detection of CRC in the Czech Republic. The burden of CRC was also assessed. Methods The novel nationwide administrative registry with individual data (period 2010-19) was used to evaluate coverage by examinations for screening faecal occult blood test and colonoscopy. In the second step, additional examinations for early CRC detection were included in the coverage calculation (complete coverage). Age-specific trends in CRC incidence (period 1977-2018) were investigated using Joinpoint regression. Results Coverage by screening examinations within recommended interval was around 30%. Complete coverage reached >37% and >50% at the 3-year interval. The coverage by examinations for the non-screening population aged 40-49 years was almost 4% and 5% (most of them were colonoscopies) at the 3-year interval. In age groups aged >= 50 years, we observed a significant annual decline, especially in the 50-69 age group, with recent annual decreases reaching up to 5-7%. The change in trend and the recent decline were also observed in the age group 40-49. Conclusions More than half of the target screening population was covered by examinations potentially associated with early detection and subsequent treatment of colorectal neoplasms. The substantial coverage by potentially prophylactic examinations might be an explanation for the considerable decrease in CRC incidence.
Návaznosti
NV18-08-00246, projekt VaV |
|